Supply Chain Intelligence

Definium Therapeutics, Inc. Supply Chain

DFTX supply chain intelligence for Definium Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

DFTX ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
2Customers
2Debt Items
20Related Chains

Definium Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
CONTRACT-MANUFACTURING-ORGANIZATIONS CONTRACT-MANUFACTURING-ORGANIZATIONS 90% the cost of manufacturing products for use in our preclinical studies and clinical trials, including payments to contract manufacturing organizations and consultants
CONTRACT-RESEARCH-ORGANIZATIONS CONTRACT-RESEARCH-ORGANIZATIONS 90% payments to third parties in connection with the clinical development of our product candidates, including licensing fees and fees to contract research organizations and consultants
THIRD-PARTIES THIRD-PARTIES 85% sponsored research arrangements with third parties
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DFTX graph: nes, damages, administrative civi…
ORANY ORANY 72% nes, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other thi…

Definium Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ORANY ORANY 72% nes, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other thi…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from DFTX graph: nes, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs.…

Definium Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
DFTX-DEBT Debt stack $40.8M 90% Market cache reports total debt of $40.8M.
DFTX-DEBT-9066 Warrants outstanding: 3767000 90% xbrl warrant detail from xbrl 2025-12-31.

Definium Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Definium Therapeutics, Inc..

Definium Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
DFTX-OWNER-AVORO-CAPITAL-ADVISORS-LLC Avoro Capital Advisors LLC 90% 13F overlay lists Avoro Capital Advisors LLC as top holder; 12 tracked holders.

Definium Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
AXSM Axsome Therapeutics, Inc. 100.00 2
ORANY ORANGE 100.00 1 ['customer', 'supplier']
DWTX Dogwood Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
JNJ Johnson & Johnson 100.00 2
D Dominion Energy, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
View DFTX supply chain intel →

Explore the full interactive supply chain map for Definium Therapeutics, Inc..

Open DFTX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map